Curative Biotechnology announces reverse stock split

Curative Biotechnology has announced a significant corporate action: a 1-for-150 reverse stock split. This move is typically undertaken by companies aiming to increase their stock price per share, often to meet exchange listing requirements or to appear more attractive to institutional investors. The reverse split will consolidate existing shares into fewer, higher-priced shares, proportionally reducing the total number of outstanding shares.